Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gold_bifidum
- Development stage
- Phase 2
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
"gold bifidum" appears to be a product name or brand for a probiotic supplement, likely containing Bifidobacterium bifidum as a key ingredient. Based on available information, "Daily Probiotics Gold" is a registered product in Australia that contains Bifidobacterium bifidum among other probiotic strains[3]. The primary use of such products is to support gut health by restoring and maintaining the balance of beneficial bacteria in the gastrointestinal tract. Bifidobacterium bifidum has been studied for its potential benefits in managing irritable bowel syndrome (IBS), supporting immune function, and possibly reducing eczema risk in infants[1][4][6]. The mechanism of action involves colonization of the gut with beneficial bacteria that compete with harmful microorganisms, modulate immune responses, and help maintain intestinal barrier integrity.
- Brand names
- gold bifidumDaily Probiotics Gold
Beyond the preview
Go deeper on gold_bifidum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gold_bifidum.